2Mรชsยท

๐‚๐ž๐ง๐ญ๐ž๐ง๐ž: ๐๐ซ๐จ๐Ÿ๐ข๐ญ๐š๐›๐ข๐ฅ๐ข๐ญ๐ฒ ๐‘๐ž๐›๐จ๐ฎ๐ง๐, ๐‘๐š๐ข๐ฌ๐ž๐ฌ ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ” ๐„๐๐’ ๐š๐ง๐ ๐‘๐ž๐ฏ๐ž๐ง๐ฎ๐ž ๐Ž๐ฎ๐ญ๐ฅ๐จ๐จ๐ค

$CNC (-1,79%)

โ €

๐Ÿ“Š ๐‘๐ž๐ฌ๐ฎ๐ฅ๐ญ๐ฌ

โ€ข EPS: $2.51 (Est. $1.08) โœ…

โ€ข Revenue: $53.58B (Est. $47.45B) โœ…

โ€ข Health Benefits Ratio: 89.6% vs. 93.0% YoY.

โ€ข Premium & service revenue: $44.38B (+4% YoY).

โ€ข Operating cash flow: $3.59B.

โ €

๐ŸŽฏ ๐†๐ฎ๐ข๐๐š๐ง๐œ๐ž

โ€ข FY2026 EPS: >$4.80 (Est. $3.52) โœ…

โ€ข FY2026 revenue: $193.5Bโ€“$197.5B (Midpoint: $195.5B vs. Est. $190.33B) โœ…

โ€ข Premium & service revenue: $173.0Bโ€“$177.0B.

โ€ข FY2026 GAAP EPS guidance raised to >$3.11.

โ €

๐Ÿ“Œ ๐Š๐ž๐ฒ ๐“๐š๐ค๐ž๐š๐ฐ๐š๐ฒ๐ฌ

โ€ข Significant profitability improvement driven by lower medical costs, stronger Medicare performance, and improved Marketplace pricing.

โ€ข Commercial Health Benefits Ratio improved to 79.2%, while Medicare HBR was 89.5% and Medicaid HBR was 93.9%, in line with expectations.

โ€ข Membership declined to 25.9M, primarily due to lower Marketplace and Medicaid enrollment, partially offset by strong Medicare PDP growth.

โ €

๐Ÿ’ฌ ๐Œ๐š๐ง๐š๐ ๐ž๐ฆ๐ž๐ง๐ญ ๐‚๐จ๐ฆ๐ฆ๐ž๐ง๐ญ๐š๐ซ๐ฒ

CEO Sarah London said Centene's improved results reflect meaningful progress in restoring profitability through stronger pricing, disciplined medical cost management, and a lower-cost operating structure, supporting the higher full-year outlook.

2
Participar na conversa